Roche posts SKYSCRAPER-01 results for tiragolumab/atezolizumab; registers Phase II Parkinson's trialNov 13Weekly roundup, 9 itemsalectinibastegolimab
Wave Life Sciences details Q3 2026 progress on WVE-006, WVE-007, WVE-008 pipelineOct 28Quarterly updateBristol Myers SquibbEli LillyUpdated
Pfizer registers four studies: elranatamab, berobenatide, tilrekimig, and completed etrasimod trialOct 23Weekly roundup, 14 itemsabrocitinibatirmociclibUpdated
Lilly posts Phase 3 results for orforglipron and lebrikizumab; discloses abemaciclib trial haltOct 16Weekly roundup, 7 itemsabemaciclibBayerUpdated
Lilly posts Phase 3 orforglipron results; registers new MDD trial and five other updatesOct 2Weekly roundup, 10 itemsbaricitinibbrenipatideUpdated
Roche posts results for lebrikizumab COPD trial; crovalimab pediatric aHUS study nears completionSep 10Weekly roundup, 3 itemsChugai Pharmaceuticalcrovalimab
Roche posts results for two Phase 3 lebrikizumab asthma trials; Operetta 2 update on pediatric MSJul 17Weekly roundup, 3 itemslebrikizumabocrelizumab
Roche's lebrikizumab asthma trial posts results; new faricimab trial planned for eye diseaseJul 2Weekly roundup, 2 itemsfaricimablebrikizumab